Suchergebnisse - "Rimassa, Lorenza"

PubPharm (370)

101

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis : A real‐world study

enthalten in: Hepatology | 2022

von D’Alessio, A. | Fulgenzi, C. | Nishida, N. | +32

102

Tumour burden score and immune‐related hepatotoxicity in patients with hepatocellular carcinoma or liver metastases treated with immune checkpoint inhibitors

enthalten in: Liver Cancer International | 2022

von Di Carlo, E. | D'Alessio, A. | Cammarota, A. | +9

103

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

enthalten in: Liver International | 2022

von Vithayathil, M. | D'Alessio, A. | Fulgenzi, C. | +32

104

Outcome of liver cancer patients with SARS‐CoV‐2 infection : An International, Multicentre, Cohort Study

enthalten in: Liver International | 2022

von Muñoz‐Martínez, S. | Sapena, V. | Forner, A. | +52

105

Risk of Cancer in Inflammatory Bowel Diseases : Umbrella Review and Reanalysis of Meta-analyses

enthalten in: Gastroenterology | 2022

von Piovani, D. | Hassan, C. | Repici, A. | +5

106

The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

enthalten in: Cancers | 2021

von Muhammed, A. | Fulgenzi, C. | Dharmapuri, S. | +36

107

Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma : matching-adjusted indirect comparison analysis

enthalten in: Journal of cancer research and clinical oncology | 2021

von Casadei-Gardini, A. | Rimassa, L. | Rimini, M. | +15

108

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

109

Safety and Efficacy of Cabozantinib for Patients with Advanced Hepatocellular Carcinoma and Child-Pugh B Liver Function: Retrospective Analysis From the CELESTIAL Randomised Controlled Trial

enthalten in: ResearchSquare.com | 2021

von El-Khoueiry, A. | Meyer, T. | Cheng, A. | +5

110

Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma

enthalten in: Liver cancer | 2021

von Fessas, P. | Naeem, M. | Pinter, M. | +32